These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2047569

  • 1. Effect of cepharanthine on doxorubicin cytotoxicity in P388 murine leukemia cells in vitro and in vivo.
    Fujimura T, Furusawa S, Kawauchi H, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):235-8. PubMed ID: 2047569
    [Abstract] [Full Text] [Related]

  • 2. Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells.
    Fujimura T, Shibata H, Maekawa I, Furusawa S, Kawauchi H, Sasaki K, Takayanagi Y.
    Jpn J Pharmacol; 1990 Dec; 54(4):464-7. PubMed ID: 2087009
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
    Kato T, Suzumura Y.
    J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
    [Abstract] [Full Text] [Related]

  • 4. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Sep; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S, Hui PZ, Fukuda Y, Tatsumi K, Mino M.
    Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
    [Abstract] [Full Text] [Related]

  • 6. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice].
    Dai ZQ, Xu JY, Yuan XJ, Cai JC.
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):69-71. PubMed ID: 8737460
    [Abstract] [Full Text] [Related]

  • 7. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV, Sitdikova SM, Kabieva AO.
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S, Fujimura T, Kawauchi H, Sasaki K, Takayanagi Y.
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
    [Abstract] [Full Text] [Related]

  • 9. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
    Moroz LV, Donenko FV, Borovkova NB, Sitdikova SM.
    Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
    [Abstract] [Full Text] [Related]

  • 10. Involvement of macrophages and cytokines into rejection mechanism of the drug-resistant and immunogenic murine lymphoma P388/adria.
    Kisseleva E, Becker M, Lemm M, Fichtner I.
    Anticancer Res; 1996 Dec; 16(4A):1971-8. PubMed ID: 8712729
    [Abstract] [Full Text] [Related]

  • 11. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.
    Cancer Res; 2000 Jun 15; 60(12):3232-8. PubMed ID: 10866316
    [Abstract] [Full Text] [Related]

  • 12. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct 15; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

  • 13. Effects of Dex-Verapamil on Doxorubicin cytotoxicity in P388 murine leukemia cells.
    Noviello E, Allievi E, Russo P, Parodi S.
    Anticancer Drug Des; 1997 Jun 15; 12(4):261-76. PubMed ID: 9199659
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
    Shibata H, Maekawa I, Furusawa S, Kawauchi H, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1990 Dec 15; 70(3):359-62. PubMed ID: 2093213
    [Abstract] [Full Text] [Related]

  • 15. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV, Donenko FV, Borovkova NB, Sitdikova SM, Kabieva AO.
    Biull Eksp Biol Med; 1990 Mar 15; 109(3):290-2. PubMed ID: 2364157
    [Abstract] [Full Text] [Related]

  • 16. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS, Chitnis MP.
    Oncology; 1990 Mar 15; 47(2):166-9. PubMed ID: 2314829
    [Abstract] [Full Text] [Related]

  • 17. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1983 Jun 15; 43(6):2905-10. PubMed ID: 6850602
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 Jun 15; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 19. Selective effect of trichotecolone on hemopoietic tumor cells.
    Goetsch L, Thomasset N, Vila J, Philip I, Doré JF.
    Anticancer Res; 1990 Jun 15; 10(4):1013-7. PubMed ID: 2382972
    [Abstract] [Full Text] [Related]

  • 20. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis.
    Furusawa S, Wu J, Fujimura T, Nakano S, Nemoto S, Takayanagi M, Sasaki K, Takayanagi Y.
    Methods Find Exp Clin Pharmacol; 1998 Mar 15; 20(2):87-97. PubMed ID: 9604850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.